Who owns AVALO THERAPEUTICS ORD?
- Ticker: AVTX
- CUSIP Number: 05338f306
Tip: Access positions for across all investors
Analyze quarterly positions in Avalo Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avalo Therapeutics Ord stock
Who bought or sold AVALO THERAPEUTICS ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 47k | $1.0M | 100% | Mar 2024 |
|
| Sio Capital Management | 10k | $221k | 100% | Mar 2024 |
|
| UBS Group | 7.7k | $170k | 385550% | Mar 2024 |
|
| ADAR1 Capital Management | 6.0k | $131k | 100% | Mar 2024 |
|
| Natixis | 2.5k | $55k | 100% | Mar 2024 |
|
| BlackRock | 2.1k | $46k | 100% | Mar 2024 |
|
| Tower Research Capital | 1.6k | $36k | 100% | Mar 2024 |
|
| Banque Cantonale Vaudoise | 338.00 | $2.0k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 322.00 | $7.0k | 133% | Mar 2024 |
|
| Morgan Stanley | 39.00 | $848.250000 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 8.00 | $174.666400 | 0% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 4.00 | $87.000000 | 100% | Mar 2024 |
|
| Group One Trading | 2.00 | $44.000000 | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 2.00 | $44.000000 | 0% | Mar 2024 |
|
| Advisor Group Holdings | 2.00 | $42.000000 | 100% | Mar 2024 |
|
| Parallel Advisors | 1.00 | $22.000000 | 100% | Mar 2024 |
|
| Old Point Trust & Financial Services N A | 1.00 | $22.000000 | 100% | Mar 2024 |
|
Who sold out of Avalo Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| FNY Investment Advisers | Dec 2023 | 522.00 | $4.0k |
| FTB Advisors | Dec 2023 | 1.00 | $9.000000 |